There is a particular patient I’ve been seeing for several years. Every time she comes in, her skin tells a different story depending on what’s been happening in her life. After a period of poor sleep and work stress, her pigmentation flares and her skin texture coarsens in a way that isn’t explained by her skincare or sun exposure. When she’s slept well, exercised consistently, and her life has been calmer — she looks meaningfully better. Not subtly. Meaningfully.
This is chronic inflammation made visible.
The term gets overused — inflammation has become a wellness catchword that now applies to everything from wrinkles to mood to weight gain, sometimes with adequate evidence and sometimes without. But the underlying biology is real, clinically measurable, and worth understanding precisely.
What inflammageing actually is
The term inflammageing — coined by immunologist Claudio Franceschi — describes the chronic, low-grade, systemic inflammatory state that characterises biological ageing. It is not acute inflammation, the kind you get from a cut or an infection. It is a persistent, subclinical activation of immune pathways that, over time, degrades tissue across every organ system including the skin.
The primary mediators are pro-inflammatory cytokines: interleukin-1β, interleukin-6, and tumour necrosis factor-alpha. These molecules, when chronically elevated, activate matrix metalloproteinases — enzymes that degrade collagen and elastin. They also stimulate melanocyte activity, which is why chronic inflammation worsens pigmentation in susceptible skin. They impair the skin’s barrier function, increase transepidermal water loss, and reduce the quality of the fibroblast response to repair stimuli [1].
In my practice at SW1 Clinic, inflammageing is not an abstract concept. I measure it. High-sensitivity CRP (hsCRP) is a useful surrogate marker — imperfect, but accessible. Patients who present with dull, textured skin and persistent pigmentation that doesn’t respond well to topical treatment often have elevated inflammatory markers when I run a blood panel. The skin isn’t the primary problem. It’s the systemic readout.
Why this is especially relevant for Asian skin
Fitzpatrick phototypes III through V have a higher baseline reactivity to inflammatory triggers. The pigmentation response to inflammation — post-inflammatory hyperpigmentation — is more pronounced in darker skin types because melanocytes in these phototypes respond more aggressively to inflammatory cytokine stimulation.
This means that the same level of systemic inflammation that might cause mild texture changes in a lighter-skinned patient will cause visible and persistent pigmentation in an Asian patient. I see this clearly: patients who flare post-illness, post-stress, or post-hormonal change with pigmentation that looks disproportionate to the apparent cause. The cause isn’t external. It’s the internal inflammatory environment expressing through the melanocyte.
Singapore’s climate compounds this. Year-round UV creates a background of cutaneous inflammation that in cooler climates would be seasonal. Add to this the air-conditioning in most workplaces and homes — which desiccates skin and impairs barrier function — and you have an environment that is chronically inflammatory at the skin level even before systemic factors are considered.
The lifestyle drivers most people underestimate
Poor sleep is one of the most potent drivers of systemic inflammation I see clinically. A single night of insufficient sleep raises IL-6 and CRP measurably. Chronic sleep disruption — which is widespread in perimenopausal women and in Singapore’s overachieving professional demographic — maintains a sustained inflammatory state that neither skincare nor treatments can fully overcome.
Dietary pattern matters. The hawker diet I love is a complicated case study here: it contains inflammatory elements (refined carbohydrates, sugar, oxidised oils in some fried foods) alongside anti-inflammatory ones (garlic, ginger, turmeric in curries, fish-based dishes). The net effect is individual, but for patients whose diet is predominantly rice-based with minimal polyphenol-rich vegetables, the inflammatory load is higher than it needs to be.
Visceral fat is independently pro-inflammatory — adipocytes in the visceral compartment secrete inflammatory cytokines directly. This is the mechanism behind the waist-circumference-to-metabolic-risk correlation. In Asian women, where visceral fat accumulates at lower BMI thresholds, this is a clinically significant point.
And chronic psychological stress. The HPA axis dysregulation from sustained stress elevates cortisol, which in the short term is anti-inflammatory but chronically becomes pro-inflammatory through glucocorticoid resistance — the receptors stop responding, and inflammatory cascades are no longer adequately suppressed [2].
What clinical evidence says about anti-inflammatory interventions
Omega-3 fatty acids — specifically EPA and DHA — have the most robust evidence base for reducing systemic inflammatory markers. A meta-analysis confirmed significant reductions in CRP and IL-6 with omega-3 supplementation at doses of 1.5–3g per day [3]. This is also one of the supplements I take personally and recommend most consistently in my practice.
Polyphenols — particularly those from green tea, berries, and curcumin — have evidence for anti-inflammatory activity at the cellular level. The bioavailability issues with curcumin specifically are real and worth noting: standard curcumin supplements are poorly absorbed without lipid or piperine co-administration. Formulation matters.
Exercise is anti-inflammatory when the dose is right. This is the interesting paradox: acute exercise raises inflammatory markers transiently, but regular moderate exercise reduces baseline inflammatory burden over time. Overtraining, conversely, sustains inflammatory elevation. The correct dose for systemic anti-inflammatory benefit appears to be moderate intensity, regular, with adequate recovery — not extreme, not sedentary.
What you can actually do
Begin with sleep. If you’re sleeping less than seven hours or your sleep quality is disrupted, addressing this is not optional if you want the rest of your anti-ageing strategy to work. The return on investment from adequate sleep — across skin quality, metabolic markers, inflammatory burden, hormonal regulation — is greater than any supplement or treatment I can offer.
Run a blood panel that includes hsCRP. If it’s elevated above 1mg/L without acute illness, that is a signal worth acting on. The action might be dietary change, exercise adjustment, sleep improvement, stress reduction, or hormonal optimisation — depending on what else the panel shows.
Prioritise omega-3s. Either through diet (two to three portions of oily fish per week, which is very achievable in Singapore given our food culture) or through supplementation. Reduce refined carbohydrate load. Add polyphenol-rich food sources genuinely, not through expensive supplements.
And take the stress conversation seriously. Not as a lifestyle add-on. As a medical priority. The inflammation it drives is as real as anything else on this list.
The face is not the problem. It is where the problem becomes visible. Treating the face without addressing systemic inflammation is like repainting walls that are damp from a leak — the aesthetic improves temporarily, but the underlying process continues unimpeded.
References
[1] Franceschi, C., & Campisi, J. (2014). Chronic inflammation (inflammageing) and its potential contribution to age-associated diseases. The Journals of Gerontology: Series A, 69(Suppl_1), S4–S9. https://doi.org/10.1093/gerona/glu057 [VERIFY — confirm before publishing]
[2] Cohen, S., et al. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences, 109(16), 5995–5999. https://doi.org/10.1073/pnas.1118355109 [VERIFY — confirm before publishing]
[3] Calder, P. C. (2017). Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochemical Society Transactions, 45(5), 1105–1115. https://doi.org/10.1042/BST20160474 [VERIFY — confirm before publishing]
